Short answer
ICU MEDICAL INC/DE (ICUI) filed an 8-K current report with the SEC on November 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q3 2026 financial results announced by ICU Medical.
ICU MEDICAL INC/DE 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q3 2026 financial results announced by ICU Medical
- Full results and management commentary contained in Exhibit 99.1
- Results disclosure gives investors the company’s latest quarterly operating update
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $560.4M, up from $537.0M, driven by Infusion Systems growth of $18.6M
- GAAP gross margin 42% vs 37%, supporting operating income of $52.3M vs $13.7M
- GAAP diluted EPS $1.07 vs $(0.14), while adjusted EPS rose to $2.44 from $2.03
- Nine-month operating cash flow $218.6M, with debt repayments of $134.7M reducing long-term debt to $1.13B
- FY2026 guidance reaffirmed, with management expecting GAAP EPS $2.89-$3.29 and adjusted EPS $8.60-$9.00 at the high end
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ICU MEDICAL INC/DE 8-K filings
Get the next ICUI 8-K as it lands
Follow ICUI for push alerts, or ask the research agent what this filing means.